This result is likely due to the high levels of glutamic acid and glycine, precursors of glutathione, present in CSL (Lusby et al., 1982)
Overexpression of a ATP13A2 orthologue in yeast was shown to impart zinc resistance (Kong et al., 2014)
Murata H, Zhang Q, Ito T, Kawakami R, Sakamoto S, Torii S, et al
Priority Applications (6) Applications Claiming Priority (4) Related Child Applications (2) Publications (1) Family ID=62624707 Family Applications (1) Country Status (5) Cited By (2) Families Citing this family (4) Citations (2) Family Cites Families (110) 2017 2017-12-18 CN CN201780079831.4A patent/CN110121330B/en active Active 2017-12-18 EP EP17883107.9A patent/EP3558246B1/en active Active 2017-12-18 US US16/470,425 patent/US11260005B2/en active Active 2017-12-18 CA CA3046037A patent/CA3046037A1/en active Pending 2017-12-18 WO PCT/CN2017/116999 patent/WO2018113634A1/en not_active Ceased 2022 2022-01-31 US US17/589,569 patent/US11596586B2/en active Active 2023 2023-02-02 US US18/105,184 patent/US11759412B2/en active Active
The shortcomings of existing medicines, the growing incidence of inflammatory disorders, and high financial costs associated with their treatment created the need to develop new therapeutic approaches for the treatment of these disorders
